Tsakiridou, G.; Papanastasiou, A.M.; Efentakis, P.; Angelerou, M.F.G.; Kalantzi, L.
Challenges in the Investigation of Therapeutic Equivalence of Locally Applied/Locally Acting Drugs in the Gastrointestinal Tract: The Rifaximin Case. Pharmaceutics 2025, 17, 839.
https://doi.org/10.3390/pharmaceutics17070839
AMA Style
Tsakiridou G, Papanastasiou AM, Efentakis P, Angelerou MFG, Kalantzi L.
Challenges in the Investigation of Therapeutic Equivalence of Locally Applied/Locally Acting Drugs in the Gastrointestinal Tract: The Rifaximin Case. Pharmaceutics. 2025; 17(7):839.
https://doi.org/10.3390/pharmaceutics17070839
Chicago/Turabian Style
Tsakiridou, Georgia, Antigoni Maria Papanastasiou, Panagiotis Efentakis, Maria Faidra Galini Angelerou, and Lida Kalantzi.
2025. "Challenges in the Investigation of Therapeutic Equivalence of Locally Applied/Locally Acting Drugs in the Gastrointestinal Tract: The Rifaximin Case" Pharmaceutics 17, no. 7: 839.
https://doi.org/10.3390/pharmaceutics17070839
APA Style
Tsakiridou, G., Papanastasiou, A. M., Efentakis, P., Angelerou, M. F. G., & Kalantzi, L.
(2025). Challenges in the Investigation of Therapeutic Equivalence of Locally Applied/Locally Acting Drugs in the Gastrointestinal Tract: The Rifaximin Case. Pharmaceutics, 17(7), 839.
https://doi.org/10.3390/pharmaceutics17070839
